Ambee Pharmaceuticals (DHA:AMBEEPHA) Treasury Stock: BDT0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT817.80
View Full Analysis

What is Ambee Pharmaceuticals Treasury Stock?

Ambee Pharmaceuticals DHA:AMBEEPHA -1.03% 18 Treasury Stock is BDT0.00 Mil as of . 20. GuruFocus rates DHA:AMBEEPHA with a GF Score™ of 18/100.

Treasury stock is the portion of shares that a company keeps in their own treasury. Ambee Pharmaceuticals's treasury stock for the quarter that ended in . 20 was BDT0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Ambee Pharmaceuticals Treasury Stock Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Treasury Stock Chart

Ambee Pharmaceuticals Annual Data
Trend
Treasury Stock

Ambee Pharmaceuticals Semi-Annual Data
Treasury Stock
DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of BDT0.00 Mil mean?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a Treasury Stock of BDT0.00 Mil as of . 20. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Ambee Pharmaceuticals and its competitors.
Is Ambee Pharmaceuticals' Treasury Stock too high?
Ambee Pharmaceuticals' current Treasury Stock is BDT0.00 Mil. Overall, Ambee Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Ambee Pharmaceuticals' Treasury Stock compare to IMNPQ?
Ambee Pharmaceuticals' Treasury Stock of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Drug Manufacturers company?
A good Treasury Stock depends on the Drug Manufacturers industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Ambee Pharmaceuticals and its competitors. Ambee Pharmaceuticals's current Treasury Stock is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambee Pharmaceuticals stock overvalued right now?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a current Treasury Stock of BDT0.00 Mil. The current Treasury Stock is BDT0.00 Mil. Ambee Pharmaceuticals' overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Ambee Pharmaceuticals (DHA:AMBEEPHA), the current Treasury Stock is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT817.80
Price